Trials / Conditions / PIK3CA Mutation-Related Tumors
PIK3CA Mutation-Related Tumors
3 registered clinical trials studyying PIK3CA Mutation-Related Tumors — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | Breast Cancer PET/CT Imaging With 68Ga-pAKTi NCT06943313 | Fudan University | — |
| Withdrawn | Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcino NCT05472220 | Pamela Munster | Phase 1 |
| Completed | A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA Mutations NCT06132932 | Shanghai Jiatan Pharmatech Co., Ltd | Phase 1 / Phase 2 |